Chembio Diagnostics, Inc.CE.MINASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.07% | -2.88% | -15.38% | +7.83% | -1.48% |
| Gross Profit Growth | +4.83% | +8.75% | -5.04% | -1.91% | +3.33% |
| EBITDA Growth | +6.30% | +22.46% | -11.76% | -15.55% | -46.21% |
| Operating Income Growth | +7.08% | +24.72% | -13.49% | -17.56% | -14.03% |
| Net Income Growth | +9.00% | +42.48% | -12.50% | -16.97% | -14.22% |
| EPS Growth | +8.33% | +42.55% | -12.50% | -18.75% | -12.82% |
| EPS Diluted Growth | +8.33% | +42.55% | -12.50% | -16.67% | -12.82% |
| Weighted Average Shares Growth | -0.10% | +0.15% | +0.09% | +0.09% | +0.30% |
| Weighted Average Shares Diluted Growth | -0.10% | +0.15% | +0.09% | +0.09% | +0.30% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +27.71% | +0.00% | +0.00% | +0.00% | -100.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -0.07% | -2.37% | -0.78% | +4.30% | +0.23% |
| Book Value per Share Growth | +11.02% | +11.53% | +11.37% | +9.40% | +8.31% |
| Debt Growth | -3.21% | -58.33% | -2.69% | -9.83% | +48.79% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +0.00% | -17.51% | +0.00% | +4.67% | +0.00% |